Novel susceptibility loci identified for osteoarthritis

July 3, 2012
Novel susceptibility loci identified for osteoarthritis
Five novel single nucleotide polymorphisms are significantly associated with osteoarthritis, including one near the nucleostemin-encoding gene, according to a study published online July 3 in The Lancet.

(HealthDay) -- Five novel single nucleotide polymorphisms (SNPs) are significantly associated with osteoarthritis, including one near the nucleostemin-encoding gene, according to a study published online July 3 in The Lancet.

Eleftheria Zeggini, Ph.D., from the Sanger Institute in Cambridge, U.K., and colleagues conducted a large genome-wide association study involving 7,410 unrelated patients with severe in the arcOGEN study (80 percent of whom had undergone total joint replacement) and 11,009 unrelated controls. The most promising signals were replicated in an independent set of up to 7,473 cases and 42,938 controls. All patients and controls involved in the study were of European descent.

The researchers identified five loci that were significantly associated with osteoarthritis and three loci just below the threshold for significance. The strongest association was seen with rs6976 on chromosome 3 (odds ratio, 1.12), which is in perfect linkage disequilibrium with rs11177, an SNP that encodes a missense within the nucleostemin-encoding gene GNL3. In functional studies, patients with osteoarthritis had increased levels of nucleostemin in chondrocytes. Other significant loci were identified on chromosomes 9 and 6, and two loci were identified on chromosome 12. One of the signals close to significance was within the FTO gene. All risk variants exerted small effects and were common.

"We have established novel loci represented by common that confer a slight risk for osteoarthritis and are associated with the clinically important phenotype of total joint replacement," the authors write. "These results provide a basis for functional studies to identify the underlying causative variants, , and molecular cause of osteoarthritis."

Several of the authors are employed by deCODE.

Explore further: Third genetic link to osteoarthritis discovered

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Third genetic link to osteoarthritis discovered

August 25, 2011
Researchers have today revealed a new gene associated with osteoarthritis. This is only the third gene to be identified for this painful and debilitating disease that affects more than 40 per cent of people aged more than ...

Pinpointing asthma susceptibility in Japanese adults

December 22, 2011
A team of geneticists has identified five specific gene regions associated with asthma susceptibility among Japanese adults. Mayumi Tamari of the RIKEN Center for Genomic Medicine, Yokohama, led the research.

Genome-wide study reveals 3 new susceptibility loci for adult asthma in Japanese population

July 31, 2011
Researchers at the RIKEN Center for Genomic Medicine (CGM), together with colleagues at Kyoto University, Tsukuba University, Harvard University, and other medical institutions have identified three new loci associated with ...

Recommended for you

Study shows prevalence of knee osteoarthritis has doubled since World War II

August 14, 2017
The average American today is twice as likely to be diagnosed with knee osteoarthritis than in the years before World War II, Harvard scientists say, but that increase can't be blamed on the reasons most might think.

Researchers find arthritis drug could treat blood cancer patients

August 3, 2017
Blood cancer sufferers could be treated with a simple arthritis drug, scientists at the University of Sheffield have discovered.

Fluid in the knee holds clues for why osteoarthritis is more common in females

June 26, 2017
Researchers have more evidence that males and females are different, this time in the fluid that helps protect the cartilage in their knee joints.

Biologics before triple therapy not cost effective for rheumatoid arthritis

May 29, 2017
Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA). ...

Drug for refractory psoriatic arthritis shows promise in clinical trial

May 24, 2017
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced ...

Cross-species links identified for osteoarthritis

May 17, 2017
New research from the University of Liverpool, published today in the journal npj Systems Biology and Applications, has identified 'cell messages' that could help identify the early stages of osteoarthritis (OA).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.